[{"address1": "3600 Green Court", "address2": "Suite 350", "city": "Ann Arbor", "state": "MI", "zip": "48105-1570", "country": "United States", "phone": "734 335 0468", "website": "https://endrainc.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Mr. Alexander Y. Tokman", "age": 61, "title": "Acting CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 67600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Thornton Ph.D.", "age": 55, "title": "Chief Technology Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 279243, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jonathan  Behr Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard  Jacroux", "age": 56, "title": "CFO & Secretary", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Freeman", "title": "Human Resources Leader", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ziad  Rouag", "title": "Head of Regulatory & Clinical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.89, "open": 6.16, "dayLow": 5.8101, "dayHigh": 6.7799, "regularMarketPreviousClose": 5.89, "regularMarketOpen": 6.16, "regularMarketDayLow": 5.8101, "regularMarketDayHigh": 6.7799, "beta": 0.74, "forwardPE": -0.011109036, "volume": 26108, "regularMarketVolume": 26108, "averageVolume": 281014, "averageVolume10days": 37140, "averageDailyVolume10Day": 37140, "bid": 4.39, "ask": 7.51, "bidSize": 200, "askSize": 200, "marketCap": 3210709, "fiftyTwoWeekLow": 4.01, "fiftyTwoWeekHigh": 2397.5, "fiftyDayAverage": 6.06454, "twoHundredDayAverage": 191.49509, "currency": "USD", "enterpriseValue": -5663675, "floatShares": 41387, "sharesOutstanding": 536908, "sharesShort": 24029, "sharesShortPriorMonth": 7658, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0464, "heldPercentInsiders": 0.00282, "heldPercentInstitutions": 0.00487, "shortRatio": 0.05, "shortPercentOfFloat": 0.0464, "impliedSharesOutstanding": 536908, "bookValue": 27.232, "priceToBook": 0.2195946, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -9565225, "trailingEps": -105.78, "forwardEps": -311.85, "lastSplitFactor": "1:35", "lastSplitDate": 1730937600, "enterpriseToEbitda": 0.595, "52WeekChange": -0.997235, "SandP52WeekChange": 0.24176979, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NDRA", "underlyingSymbol": "NDRA", "shortName": "ENDRA Life Sciences Inc.", "longName": "ENDRA Life Sciences Inc.", "firstTradeDateEpochUtc": 1498829400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "4f58a07b-98f8-33d8-a09e-400537b24390", "messageBoardId": "finmb_52323443", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.98, "targetHighPrice": 2625.0027, "targetLowPrice": 2625.0027, "targetMeanPrice": 2625.0027, "targetMedianPrice": 2625.0027, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 6400732, "totalCashPerShare": 154.629, "ebitda": -9520298, "totalDebt": 549128, "quickRatio": 4.741, "currentRatio": 4.972, "debtToEquity": 6.106, "returnOnAssets": -0.60942, "returnOnEquity": -1.20132, "freeCashflow": -2476578, "operatingCashflow": -9000946, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-11"}]